twitter.com Open in urlscan Pro
104.244.42.193  Public Scan

Form analysis
1 forms found in the DOM

#

<form action="#" aria-label="Twitter durchsuchen" role="search" class="r-1oszu61 r-1phboty r-1yadl64 r-deolkf r-6koalj r-13awgt0 r-eqz5dr r-crgep1 r-ifefl9 r-bcqeeo r-t60dpp r-bnwqim r-417010">
  <div class="css-1dbjc4n r-1wbh5a2">
    <div class="css-1dbjc4n r-1sw30gj r-42olwf r-sdzlij r-1phboty r-rs99b7 r-eqz5dr r-16y2uox r-1wbh5a2 r-1777fci">
      <div class="css-1dbjc4n">
        <div class="css-1dbjc4n r-1awozwy r-18u37iz"><label class="css-1dbjc4n r-1dqbpge r-13awgt0 r-18u37iz" data-testid="SearchBox_Search_Input_label">
            <div class="css-1dbjc4n r-7q8q6z r-6koalj r-1777fci"><svg viewBox="0 0 24 24" aria-hidden="true" class="r-14j79pv r-4qtqp9 r-yyyyoo r-1xvli5t r-dnmrzs r-4wgw6l r-f727ji r-bnwqim r-1plcrui r-lrvibr">
                <g>
                  <path
                    d="M21.53 20.47l-3.66-3.66C19.195 15.24 20 13.214 20 11c0-4.97-4.03-9-9-9s-9 4.03-9 9 4.03 9 9 9c2.215 0 4.24-.804 5.808-2.13l3.66 3.66c.147.146.34.22.53.22s.385-.073.53-.22c.295-.293.295-.767.002-1.06zM3.5 11c0-4.135 3.365-7.5 7.5-7.5s7.5 3.365 7.5 7.5-3.365 7.5-7.5 7.5-7.5-3.365-7.5-7.5z">
                  </path>
                </g>
              </svg></div>
            <div class="css-1dbjc4n r-16y2uox r-1wbh5a2">
              <div dir="auto" class="css-901oao r-18jsvk2 r-6koalj r-37j5jr r-a023e6 r-16dba41 r-rjixqe r-bcqeeo r-qvutc0"><input aria-activedescendant="typeaheadFocus-0.7484108803340923" aria-autocomplete="list" aria-label="Suchanfrage"
                  aria-owns="typeaheadDropdown-2" autocapitalize="sentences" autocomplete="off" autocorrect="off" placeholder="Twitter durchsuchen" role="combobox" spellcheck="false" enterkeyhint="search" type="text" dir="auto"
                  class="r-30o5oe r-1niwhzg r-17gur6a r-1yadl64 r-deolkf r-homxoj r-poiln3 r-7cikom r-1ny4l3l r-xyw6el r-y0fyvk r-1dz5y72 r-fdjqy7 r-13qz1uu" data-testid="SearchBox_Search_Input" value=""></div>
            </div>
            <div class="css-1dbjc4n r-6koalj r-1777fci"></div>
          </label></div>
      </div>
    </div>
  </div>
  <div class="css-1dbjc4n r-13awgt0 r-bnwqim"></div>
</form>

Text Content

JAVASCRIPT IST NICHT VERFÜGBAR.

Wir haben festgestellt, dass JavaScript in diesem Browser deaktiviert ist.
Aktiviere JavaScript bitte oder wechsle zu einem unterstützten Browser, um
twitter.com weiter zu nutzen. Eine Liste der unterstützten Browser findest du in
unserem Hilfe-Center.

Hilfe-Center

Allgemeine Geschäftsbedingungen Datenschutzrichtlinien Cookie-Richtlinie
Impressum Anzeigen-Info © 2022 Twitter, Inc.

Lass dir nichts Neues entgehen
Wer auf Twitter ist, weiß als Erster Bescheid.
Anmelden
Registrieren
Hat jemand … Cookies gesagt?
Twitter und seine Partner verwenden Cookies, um dir einen besseren, sichereren
und schnelleren Dienst zu bieten und um unser Unternehmen zu unterstützen.
Einige Cookies sind notwendig, um unsere Dienste zu nutzen, unsere Dienste zu
verbessern und sicherzustellen, dass sie ordnungsgemäß funktionieren. Zeige mehr
über deine Auswahlmöglichkeiten.
Alle Cookies akzeptieren
Unwesentliche Cookies ablehnen

Entdecken
Einstellungen
PHARMTECH GROUP

9.484 Tweets


Neue Tweets ansehen
Folgen
Klicken, wenn du PharmTechGroup Folgen möchtest
PharmTech Group
@PharmTechGroup

Bringing you the latest news, trends, and insight circulating the global
pharmaceutical development and manufacturing industry.
UK + USAPharmTech.comSeit Februar 2009 bei Twitter
617 Folge ich
15.721 Follower
Tweets

Tweets und Antworten

Medien

Gefällt mir




TWEETS VON PHARMTECH GROUP

PharmTech Group

@PharmTechGroup
·
3 Std.

Empowering a New Era of Patient-Centric Medicines with Nanoform Technologies
Christian Jones, CCO of Nanoform, discusses what it truly means to be
patient-centric in the modern pharmaceutical industry. Podcast and DD available
now:
pharmtech.com
Empowering a New Era of Patient-Centric Medicines With Nanoform Technologies
Join Christian Jones, CCO of Nanoform, as he discusses what it truly means to be
patient-centric in the modern pharmaceutical industry. Discover the challenges
pharma companies are facing as they...

PharmTech Group

@PharmTechGroup
·
8. Sep.

In partnership with the University of Pittsburgh,
@elevatebio
will open its next manufacturing center in Pittsburgh. Full story here:
pharmtech.com
ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge
BioManufacturing...
In partnership with the University of Pittsburgh, ElevateBio will open its next
manufacturing center in the city.

PharmTech Group

@PharmTechGroup
·
8. Sep.

Roche’s $250 million acquisition of Good Therapeutics grants them rights to the
company's conditionally activated PD-1-regulated IL-2 program. Full story here:
pharmtech.com
Roche to Acquire Good Therapeutics for $250 Million
Roche’s acquisition of Good Therapeutics grants them rights to the company's
conditionally activated PD-1-regulated IL-2 program.

PharmTech Group

@PharmTechGroup
·
7. Sep.

Following a collaboration agreement, Touchlight will expand Lonza’s end-to-end
offering for mRNA manufacturing with an additional, differentiated source of DNA
raw material.
@LonzaGroup
@TouchlightDNA
Full story here:
pharmtech.com
Lonza and Touchlight Enter mRNA Collaboration
Touchlight will expand Lonza’s end-to-end offering for mRNA manufacturing with
an additional, differentiated source of DNA raw material.

PharmTech Group

@PharmTechGroup
·
7. Sep.

Lynparza has been approved in Great Britain as an adjuvant treatment for
patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.
@AstraZeneca
Read full article here:
pharmtech.com
Lynparza Approved in Great Britain
Lynparza has been approved in Great Britain as an adjuvant treatment for
patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.
1

PharmTech Group

@PharmTechGroup
·
7. Sep.

FDA has approved Sanofi's Xenpozyme (olipudase alfa-rpcp), making it the only
approved treatment for acid sphingomyelinase deficiency. Full story here:
pharmtech.com
FDA Approves Novel ASMD Treatment from Sanofi
Sanofi’s Xenpozyme (olipudase alfa-rpcp) is now the only approved treatment for
acid sphingomyelinase deficiency.

THEMEN ZUM FOLGEN


Lass dich registrieren, um Tweets über die Themen, denen du folgst, in deiner
Startseiten-Timeline zu sehen.


CAROUSEL

1. FC Nürnberg
Fußball
Sport
Spiele
Videospiele
Katzen
Anime
Apple
Fernsehen
E-Sports
Musik
Tiere
Automobilsport
Pop
Premier League
Bundesliga
Kryptowährung
Unterhaltung
Wissenschaft
K-Pop
Formel 1
Hunde
Hip Hop
Prominente
Herr der Ringe
Reisen
Galatasaray S.K.
Borussia Dortmund
Weltraum
Genshin Impact


PharmTech Group

@PharmTechGroup
·
7. Sep.

Aria Pharmaceuticals has filed for six patent applications for programs
concerning lupus, idiopathic pulmonary fibrosis, and chronic kidney disease.
Full story here:
pharmtech.com
Aria Pharmaceuticals Files Applications for Six Provisional Patents
The patent applications are for programs concerning lupus, idiopathic pulmonary
fibrosis, and chronic kidney disease.

PharmTech Group

@PharmTechGroup
·
2. Sep.

Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to
expand its sickle cell and rare blood disorder portfolio.
@novonordisk
@FORMAInc
Full Story Here:
pharmtech.com
Novo Nordisk to Acquire Forma Therapeutics for $1.1 Billion
Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to
expand its sickle cell and rare blood disorder portfolio.

PharmTech Group

@PharmTechGroup
·
2. Sep.

FDA has issued an emergency use authorization for both the Pfizer-BioNTech and
Moderna bivalent COVID-19 boosters. Full story here:
pharmtech.com
FDA Authorizes Bivalent COVID-19 Boosters
FDA has issued an emergency use authorization for both the Pfizer-BioNTech and
Moderna bivalent COVID-19 boosters.
1
1

PharmTech Group

@PharmTechGroup
·
31. Aug.

Lonza has introduced X-ray powder diffraction capability at its Monteggio,
Switzerland site.
@LonzaGroup
Read full article here:
pharmtech.com
Lonza Strengthens Micronization Portfolio with the Introduction of X-Ray Powder
Diffraction
Lonza has introduced X-ray powder diffraction capability at its Monteggio,
Switzerland site.
1

PharmTech Group

@PharmTechGroup
·
31. Aug.

Forecyte Bio and Cytiva will team up to accelerate the development and
manufacturing of cell and gene therapies.
@Cytiva
Read full article here:
pharmtech.com
Forecyte Bio and Cytiva to Collaborate on Cell and Gene Therapy Manufacturing
and Development
Forecyte Bio and Cytiva will team up to accelerate the development and
manufacturing of cell and gene therapies.

NEU BEI TWITTER?


Registriere dich jetzt, um deine eigene personalisierte Timeline zu erhalten!
Mit Apple registrieren
Mit Telefonnummer oder E-Mail-Adresse registrieren
Indem du dich registrierst, stimmst du den Allgemeinen Geschäftsbedingungen und
Datenschutzrichtlinien sowie der Nutzung von Cookies zu.

WAS DIR GEFALLEN KÖNNTE


Pharmaceutical News

@PharmaIQ
Folgen
Klicken, wenn du PharmaIQ Folgen möchtest
PharmaVoice

@PharmaVoice
Folgen
Klicken, wenn du PharmaVoice Folgen möchtest
European Pharmaceutical Review

@PharmaReview
Folgen
Klicken, wenn du PharmaReview Folgen möchtest
Mehr anzeigen


AKTUELLE TRENDS

TRENDS FÜR DICH


Trend in Deutschland
Diana
852.000 Tweets

Trend in Deutschland
Ukrainer
2.805 Tweets

Politik · Trends
London Bridge
269.000 Tweets

Trend in Deutschland
jatta

Trend in Deutschland
Jenny
24.000 Tweets

Politik · Trends
Camilla
144.000 Tweets

Trend in Deutschland
Soziale Unruhen
3.138 Tweets

Politik · Trends
Inflation
115.000 Tweets

Politik · Trends
Her Majesty
584.000 Tweets

Trend in Deutschland
#GoodbyeDeutschland

Mehr anzeigen
Allgemeine
GeschäftsbedingungenDatenschutzrichtlinienCookie-RichtlinieImpressumBarrierefreiheitAnzeigen-Info
Mehr
© 2022 Twitter, Inc.